VATEIndustrials · Engineering & ConstructionTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 93 of 100 as at 14 Oct 2026 — among the strongest tenth.
Consensus tells you what everyone already believes. The model scores INNOVATE Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (100): Sales and profits are climbing, and climbing faster than before.
Revisions (25): Analysts have, on balance, been cutting their forecasts.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on VATE, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. VATE appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, INNOVATE Corp. returned +28.1% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 84% of US stocks
Cheaper than 97% of US stocks
Cheaper than 94% of US stocks
Cheaper than 46% of US stocks
Higher than 90% of US stocks
Higher than 80% of US stocks
Higher than 20% of US stocks
Higher than 61% of US stocks
Higher than 28% of US stocks
Higher than 87% of US stocks
Higher than 73% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
INNOVATE Corp. has a market value of $87.0M and an enterprise value of $713.1M.
Revenue in the twelve months to 30 June 2026: $1.5B. The latest quarter grew 74.2% year on year.
Net income over the same four quarters: −$21.9M, a −1.4% net margin.
Diluted earnings per share, trailing twelve months: $−1.87.
Free cash flow in the twelve months to 30 June 2026: $106.0M.
INNOVATE Corp. spent $1.8M on dividends in the twelve months to 30 June 2026.
Trailing P/E: −1.3×.
Forward dividend yield: 0.00%, paying out 0% of earnings.
INNOVATE Corp. employs 3,587 people — $423K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own INNOVATE Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
INNOVATE completed the sale of DBM Global for about $413 million in cash plus IES shares. Net proceeds are earmarked for debt reduction and increased financial flexibility.
Why it matters — VATE watchers may note the sale proceeds are intended to reduce the company’s debt and improve flexibility.
INNOVATE Corp. (NYSE: VATE) announced it has completed the previously announced sale of DBM Global, Inc. to IES Holdings, Inc. (Nasdaq: IESC), pursuant to the transaction agreement first announced on August 10, 2026.
Why it matters — This closing completes a previously announced divestiture, marking the finalization of a significant corporate transaction that INNOVATE shareholders were monitoring.
INNOVATE Corp. announced the closing of the sale of a controlling interest in its broadcasting segment to CONX, as announced via GlobeNewsWire from New York on September 2, 2026.
Why it matters — This corporate transaction changes the ownership structure of INNOVATE's broadcasting business, so VATE watchers may want to track how the divestiture affects the company's operations and reporting.
INNOVATE Corp. reported improved Q2 results year-over-year, swinging to a profit as revenues surged 74.2%, driven by DBM Global's growth, wider margins, and backlog gains. The company's debt and liquidity remain areas of focus.
Why it matters — The earnings improvement and strong revenue growth signal strengthening infrastructure operations, while debt and liquidity levels remain key considerations for VATE watchers.
INNOVATE Corp. announced that The Galien Foundation has nominated the MediBeacon TGFR System, developed by its equity method investment MediBeacon Inc., for the 2026 Prix Galien USA Best Medical Technology award.
Why it matters — A Prix Galien nomination is a significant industry recognition that could raise the profile of MediBeacon, a company in which INNOVATE holds an equity method investment.
As at 14 Oct 2026, INNOVATE Corp. ranks 93 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (100 of 100).
No analyst covering INNOVATE Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for VATE are extrapolating price history, which says nothing about the business.
INNOVATE Corp. returned +28.1% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
INNOVATE Corp. is a diversified holding company focused on three operating segments: Infrastructure, Life Sciences, and Spectrum.
The most recent item we track (Zacks Investment Research, 6 Oct 2026): "INNOVATE Completes DBM Global Sale, Targets Debt Reduction". INNOVATE completed the sale of DBM Global for about $413 million in cash plus IES shares. Net proceeds are earmarked for debt reduction and increased financial flexibility.
INNOVATE Corp. is a diversified holding company focused on three operating segments: Infrastructure, Life Sciences, and Spectrum. Through its subsidiaries, the company provides industrial construction, structural steel fabrication, heavy equipment installation, facility maintenance, and specialized engineering services for commercial and infrastructure projects. Its Life Sciences business develops products aimed at early knee osteoarthritis treatment and skin-focused aesthetic and medical technologies. The Spectrum segment operates over-the-air broadcasting stations across the United States, adding media assets to its broader portfolio. INNOVATE Corp. serves markets tied to construction, healthcare innovation, and broadcasting, with a business model centered on owning and managing a range of operating subsidiaries across these areas.
3,587 employees · United States · https://innovatecorp.com
